C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Associate Director - Clinical Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$192.7k - $226.7k

About the Job

Requirements

  • Ability to prepare for and defend regulatory agency inspections.
  • Ability to perform Good Clinical Practice audits.
  • Experience developing Good Clinical Practice standard operating procedures and training personnel on those procedures and applicable government regulations.
  • Thorough understanding of quality systems supporting internal Good Clinical Practice activities for clinical documentation and clinical trials.
  • Proficiency with Microsoft Office applications, including Word, Excel, and PowerPoint.
  • A BA/BS degree in biological sciences, pharmacy, a related field, or equivalent experience is required.
  • At least 10 years of experience developing and maintaining clinical quality systems and performing Good Clinical Practice audits for clinical-stage pharmaceutical companies.

Responsibilities

  • Lead Clinical Quality Assurance activities and oversee assigned CQA team members to ensure compliance oversight of all clinical studies within a clinical development program.
  • Support management and growth of the CQA team, including attracting and developing talent, creating a rewarding professional environment, and ensuring the team's capabilities meet current and future needs.
  • Develop and manage study audit plans to ensure compliance oversight for assigned studies using a risk-based approach.
  • Lead and manage Good Clinical Practice audits, including clinical investigator site, Trial Master File, and applicable study document audits, including Clinical Study Reports.
  • Support clinical service provider and clinical development internal process audits.
  • Assess changes to qualified service provider services and their impact on ongoing clinical studies.
  • Serve as a CQA Lead representative on assigned clinical studies and provide compliance support and oversight throughout each study lifecycle.
  • Evaluate new processes and initiatives affecting clinical programs and studies as the CQA representative, and support implementation as needed.
  • Support clinical study teams in risk management activities, including identifying critical-to-quality factors for each study, implementing risk-proportionate study activities in accordance with those factors, and monitoring identified risks.
  • Review clinical study documents and plans, and provide CQA compliance review and approval of clinical development standard operating procedures.
  • Manage and support Good Clinical Practice inspection-readiness activities for assigned clinical programs and studies in alignment with study milestones.
  • Support regulatory inspections in a key role for assigned programs, including sponsor, clinical investigator site, and service provider inspections.
  • Lead critical investigations to ensure regulatory reporting compliance.
  • Support, review, and approve clinical non-compliance records, including deviations and corrective and preventive actions.
  • Lead continuous improvement of the Clinical Quality Management System, including creating and revising standard operating procedures and training programs for Good Clinical Practice compliance and excellence.
  • Maintain contemporary knowledge of agency and industry trends, standards, and methodologies related to Good Clinical Practices.
  • Provide cross-training and development opportunities, and mentor and coach junior Quality Assurance team members.
  • Travel as required.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs